Don’t Look to the Income Statement to Gauge Company Health

At Prospector, when we evaluate a company our first objective is to assess its downside risk. We do this by looking at the balance sheet first, followed by the cash flow statement, and finally the income statement. This is the inverse of how most equity analysts approach fundamental analysis and how management teams typically discuss their financials on quarterly earnings calls. The income statement is of the least importance to us simply because it’s the easiest financial statement to manipulate and, for a variety of reasons, company executives do not hesitate to make substantial adjustments to their earnings in order to paint the rosiest possible picture for investors.

“When we evaluate a company our first objective is to assess its downside risk. We do this by looking at the balance sheet first, followed by the cash flow statement, and finally the income statement.”

 

Record Level of Earnings Adjustments in 2022

A recent study conducted by research firm Calcbench, which looked at the earnings from 200 S&P 500 companies in 2022, revealed that on average, non-GAAP net income exceeded the corresponding GAAP figure by $1.1 billion. The adjustments represented an impressive 38% of GAAP net income, up from 14% in 2021. Of the companies that reported non-GAAP earnings, 83% adjusted their net income upward.

 

Non-GAAP Earnings: An Unreliable Indicator of Company Health

Now faced with increasing scrutiny from the SEC, management teams argue that adjusted earnings figures represent the performance of their company’s “core” operations, helping investors differentiate the impact of one-off events from the performance of the underlying business. While this is true to an extent, companies have become dependent on these tactics in order to shine a positive light on their business. We think prudent investors should avoid relying too heavily on non-GAAP earnings as a measure of company health.

2023.06 Prospector Blog Gauge Company Health Chart1
Source: Calcbench


Academic studies have indicated that adjustments to the income statement are more frequent and larger when economic conditions are deteriorating. It’s also notable that executive compensation packages are commonly determined by non-GAAP financial measures. In a 2022 publication from MIT’s Robert Pozen, it was shown that firms reporting the largest difference between GAAP and adjusted earnings awarded higher pay packages to their CEOs and were more likely to beat the earnings targets specified in their compensation plans.

“Academic studies have indicated that adjustments to the income statement are more frequent and larger when economic conditions are deteriorating.”

Alas, the obvious conflicts of interest surrounding income statement adjustments do not prevent many investors from basing their investment decisions around simplistic metrics like the P/E ratio, which we pay relatively less attention to. Deep fundamental analysis remains at the heart of our practice, and that means rolling up our sleeves to identify companies with resilient balance sheets, strong free cash flow generation, and management teams that act in the best interest of their shareholders. Our approach to equity analysis, which resembles the way fixed income analysts approach credit investing, involves scrupulous financial modeling, regulatory and statutory financial statement decomposition, and direct conversations with the company. We believe our steadfast focus on downside risk mitigation will continue to produce superior risk-adjusted returns across market cycles.

 

For more information on our balance sheet-first approach, click here.

Sign Up To Receive Our Market Insights.

 

 

The views described herein do not constitute investment advice, are not a guarantee of future performance, and are not intended as an offer or solicitation with respect to the purchase or sale of any security. Investing involves risk, including loss of principal. Investors should consider the investment objective, risks, charges and expenses of a Fund carefully before investing. Please review the offering memorandum or prospectus of a Fund for a complete discussion of the Fund’s risks which include, but are not limited to: possible loss of principal amount invested; stock market risk; value risk; interest rate risk; income risk; credit risk; foreign securities risk; currency risk and derivatives risk.

Nothing contained herein constitutes investment, legal, tax, or other advice nor should be relied upon in making an investment or other decision. Any projections, outlooks or estimates contained herein are forward looking statements based upon specific assumptions and should not be construed as indicative of any actual events that have occurred or may occur. 

This site uses cookies to enhance your website experience. By subscribing to our Market Insights, you are agreeing to our use of cookies. See our cookie policy here